NCT02177643View on ClinicalTrials.gov

Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin

PHASE2UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

August 31, 2016

Conditions
Diabetes-Related ComplicationsDiabetes Mellitus, Type 2Insulin Resistance
Interventions
DRUG

Diacerein

Diacerein oral capsules

DRUG

Placebo

Placebo oral capsules

Trial Locations (3)

Unknown

RECRUITING

Centro de Estudos em Diabetes e Hipertensão, Fortaleza

RECRUITING

Universidade Estadual de Feira de Santana, Feira de Santana

RECRUITING

Universidade Estadual de Campinas, Campinas

Sponsors

Collaborators (1)

ANS Pharma
All Listed Sponsors
collaborator

Conselho Nacional de Desenvolvimento Científico e Tecnológico

OTHER_GOV

collaborator

ANS Pharma

INDUSTRY

lead

University of Campinas, Brazil

OTHER

NCT02177643 - Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin | Biotech Hunter | Biotech Hunter